← Back to Search

MTPS9579A for Asthma

Phase 2
Waitlist Available
Research Sponsored by Genentech, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up predose on weeks 6 and 14
Awards & highlights

Study Summary

This trial will test a new drug to see if it helps people with asthma who are already taking other medications. The new drug will be given as an add-on therapy.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~predose on weeks 6 and 14
This trial's timeline: 3 weeks for screening, Varies for treatment, and predose on weeks 6 and 14 for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Time to First Composite Asthma Exacerbations (CompEX) Event
Secondary outcome measures
Absolute Change From Randomization in Fractional Exhaled Nitric Oxide (FeNO) at Week 50
Absolute Change From Randomization in Pre-Bronchodilator Forced Expiratory Volume in 1 Second (FEV1) at Week 50
Area Under Concentration-Time Curve for the First Dosing Interval (AUClast) of MTPS9579A
+11 more

Side effects data

From 2022 Phase 2 trial • 135 Patients • NCT04092582
28%
Asthma
9%
COVID-19
7%
Headache
6%
Nasopharyngitis
4%
Arthralgia
1%
Abortion spontaneous
1%
Clavicle fracture
1%
Dermatitis
1%
Accidental death
1%
Back pain
100%
80%
60%
40%
20%
0%
Study treatment Arm
MTPS9579A, 1800 mg
Placebo

Trial Design

2Treatment groups
Experimental Treatment
Placebo Group
Group I: MTPS9579AExperimental Treatment1 Intervention
Group II: PlaceboPlacebo Group1 Intervention
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
MTPS9579A
2019
Completed Phase 2
~140

Find a Location

Who is running the clinical trial?

Genentech, Inc.Lead Sponsor
1,539 Previous Clinical Trials
567,554 Total Patients Enrolled
50 Trials studying Asthma
21,377 Patients Enrolled for Asthma
Clinical TrialsStudy DirectorHoffmann-La Roche
2,200 Previous Clinical Trials
888,387 Total Patients Enrolled
20 Trials studying Asthma
6,222 Patients Enrolled for Asthma

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of MTPS9579A in Patients With Asthma Requiring Inhaled Corticosteroids and a Second Controller
2019. "A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of MTPS9579A in Patients With Asthma Requiring Inhaled Corticosteroids and a Second Controller". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT04092582.
~25 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top